batyushkinuxit.blogspot.com
Xanodyne Pharmaceuticals is a privately-owned company backed by some of the foremos t private capital investorsin healthcare. Although a young company, Xanodyne has already establishefd itself as a strong and competent entit in the branded specialtypharmaceutical industry. Xanodynde Pharmacal, Inc. was founded in July of 2001 in the Greaterr Cincinnati area byRoger Griggs, Chairman of Union Springw LLC, a private equity group that focuses exclusively on investmentsd in the life sciences sector, and Dr. Gilberty Gonzales, a neurologist and pain management specialist. Since its Xanodyne has set a rapid pace of developmentand acquisitions.
In 2001, it acquire Drug Enhancement Company of America LLC a privately held pharmaceutical productydevelopment company. This acquisitiohn not only increased the numberof near-term pharmaceuticapl development projects, which complemented Xanodyne'a strategic direction, but it also brought expertisw and talented employees from DECA to Xanodyne. In early Xanodyne Pharmacal, Inc. merged with Indianapolis-based Integrity Inc., (a womens health specialty company) with the newlg merged company being renamedXanodynr Pharmaceuticals, Inc.
In July of 2005, Xanodyne completed a transaction to acquire most of the assetesof aaiPharma's pharmaceuticals The deal value was in exces s of $200 million in
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment